July 23, 2016 8:00 AM ET

Healthcare Equipment and Supplies

Company Overview of Tandem Diabetes Care, Inc.

Company Overview

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. The company’s flagship product is the t:slim insulin delivery system that comprises t:slim pump, its disposable insulin cartridge, and an infusion set. It also provides t:flex insulin delivery system that includes t:flex pump, its 480-unit disposable insulin cartridge, and an infusion set; and t:slim G4 insulin delivery system, a touch-screen pump with an integrated CGM system. In addition, the company offers t:connect diabetes management application, a cloud-based data management application, which provides a visual way...

11045 Roselle Street

San Diego, CA 92121

United States

Founded in 2006

482 Employees

Phone:

858-366-6900

Key Executives for Tandem Diabetes Care, Inc.

Chief Executive Officer, President and Director
Age: 64
Total Annual Compensation: $566.3K
Chief Financial Officer, Executive Vice President and Treasurer
Age: 50
Total Annual Compensation: $360.4K
Chief Operating Officer and Executive Vice President
Age: 61
Total Annual Compensation: $360.4K
Compensation as of Fiscal Year 2015.

Tandem Diabetes Care, Inc. Key Developments

Tandem Diabetes Care, Inc. Receives FDA Clearance of Remote Software Update Tool for Insulin Pumps

Tandem Diabetes Care®, Inc. announced U.S. Food and Drug Administration (FDA) clearance of the Tandem Device Updater, a Mac® and PC-compatible tool for the remote update of Tandem insulin pump software.  The first use of the Tandem Device Updater will be for deployment of the latest t:slim® Insulin Pump software to in-warranty t:slim Pumps purchased before April 2015. This updated software began shipping on new t:slim Pumps as of April 2015 and includes a variety of product enhancements for convenience and flexibility. Future software improvements and enhancements will be implemented through the Tandem Device Updater as they are cleared for commercial distribution. The company intends to roll out the Tandem Device Updater first to early t:slim Pump users throughout the summer in a series of test groups, followed by an expanded launch later this year.

Tandem Diabetes Care, Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2016; Revises Earnings Guidance for the Year 2016; Provides Earnings Guidance for the Fourth Quarter of 2016

Tandem Diabetes Care, Inc. reported unaudited earnings results for the first quarter ended March 31, 2016. For the quarter, the company reported sales of $20,058,000 against $12,308,000 a year ago. Operating loss was $19,238,000 against $20,410,000 a year ago. Net loss was $20,484,000 against $21,208,000 a year ago. Basic and diluted net loss per share was $0.68 against $0.83 a year ago. For the year 2016, the company now estimates sales to be in the range of $108 million to $115 million, which represents annual sales growth of 48% to 58% compared to 2015. The company's prior sales guidance range was $105 million to $112 million. Approximately $5.0 million to $6.0 million of depreciation and amortization. For the fourth quarter of 2016, the company expects EBITDA-positive.

Tandem Diabetes Care, Inc. to Report Q1, 2016 Results on Apr 28, 2016

Tandem Diabetes Care, Inc. announced that they will report Q1, 2016 results After-Market on Apr 28, 2016

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Tandem Diabetes Care, Inc., please visit www.tandemdiabetes.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.